Literature DB >> 102116

High versus low dose rate intracavitary irradiation of carcinoma of the uterine cervix. A preliminary report.

T Inoue, S Hori, Y Miyata, S Ozeki, Y Shigematsu.   

Abstract

Overall 2-year actuarial survival rates were 77 and 81 per cent in a high and a low dose rate group, respectively. In the high dose rate group 60 patients were controlled, 8 developed rectal bleeding, and 7 recurred. In the low dose rate group 54 were controlled, one developed rectal bleeding, and 9 recurred. Optimum TDF was 125 in both groups.

Entities:  

Mesh：

Year:  1978        PMID： 102116     DOI： 10.3109/02841867809127929

Source DB:  PubMed          Journal:  Acta Radiol Oncol Radiat Phys Biol        ISSN： 0348-5196


  3 in total

1.  Intracavitary brachytherapy for carcinoma of the uterine cervix--comparison of HDR (Ir-192) and MDR (Cs-137).

Authors:  Eiichi Tanaka; Osamu Suzuki; Ryoong-Jin Oh; Takashi Takeda; Teruki Teshima; Toshihiko Inoue; Takehiro Inoue
Journal:  Radiat Med       Date:  2006-01

2.  HDR and MDR intracavitary treatment for carcinoma of the uterine cervix. A prospective randomized study.

Authors:  M el-Baradie; T Inoue; T Inoue; S Murayama; J T Tang; H Yamazaki; N Fournier-Bidoz
Journal:  Strahlenther Onkol       Date:  1997-03       Impact factor: 3.621

Review 3.  High dose rate versus low dose rate intracavity brachytherapy for locally advanced uterine cervix cancer.

Authors:  Ruifeng Liu; XiaoHu Wang; Jin Hui Tian; KeHu Yang; Jun Wang; Lei Jiang; Xiang Yong Hao
Journal:  Cochrane Database Syst Rev       Date:  2014-10-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.